Skip to main content
SpringerLink
Log in

Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls

  • Published:
Experimental Brain Research Aims and scope Submit manuscript

Summary

Fetal substantia nigra (SN) cells were transplanted into the caudate nucleus (CN) of four vervet monkeys (Cercopithecus aethiops sabaeus) that had been treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). MPTP treatment appears to produce a syndrome similar to that observed in patients with idiopathic Parkinson's disease. Normal and parkinsonian behaviors were quantitated by trained observers 5 days/week. Twenty-eight behaviors based on previous factor analyses were individually scored and rated. Parkinsonian signs included freezing, head and limb tremor, difficulty in eating, delayed initiation of movement, poverty of movement, tremor that stopped with intention, decreased response to threats, and lying immobile in the cage. These signs were combined to give an overall rating of parkinsonism. A summary measure of ‘normal’ healthy behavior was also examined, including such behaviors as yawning, scratching, self-grooming, shifting, and eating. Overall ratings of parkinsonism increased and those of healthy behavior decreased after MPTP. In the 4 monkeys grafted with fetal SN cells into the CN, behavior returned to pre-treatment levels by the time of sacrifice (2, 5, or 7.5 months after grafting). Three control subjects were transplanted with either SN cells into an inappropriate brain site (cortex) or inappropriate, non-dopaminergic, cells (cerebellar) into the CN. Subjects were also compared with three control animals that did not receive MPTP but received cryopreserved or fresh SN and other cells into the CN. Only MPTP-treated subjects that received SN cells into the CN showed evidence of a reversal of the MPTP syndrome after transplantation. In addition, grafting in animals that were not MPTP-treated did not appear to affect behavior. This paper reports the specific behavioral effects of severe MPTP toxicity that were or were not reversed after transplantation and suggests that only fetal SN cells grafted into the CN may be able to reverse behavioral deficits in MPTP-treated monkeys.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Altman J (1974) Observational study of behavior: sampling methods. Behavior 49: 222–267

    Google Scholar 

  • Bankiewicz KS, Oldfield EH, Chiueh CC, Doppman JL, Jacobowitz DM, Kopin IJ (1986) Hemiparkinsonism in monkeys after unilateral internal carotid artery infusions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci 39: 7–16

    Google Scholar 

  • Baulu J, Redmond DE Jr (1978) Some sampling considerations in the quantitation of monkey behavior under field and captive conditions. Primates 19: 391–399

    Google Scholar 

  • Benecke R, Rothwell JC, Dick JPR, Day BL, Marsden CD (1987) Disturbance of sequential movements in patients with Parkinson's disease. Brain 110: 361–379

    Google Scholar 

  • Björklund A, Stenevi U (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177: 555–560

    Google Scholar 

  • Björklund A, Stenevi U (1984) Intracerebral neural implants: neuronal replacement and reconstruction of damaged circuitries. Ann Rev Neurosci 7: 279–308

    Google Scholar 

  • Björklund A, Stenevi U, Dunnett SB, Iversen SD (1981) Functional reactivation of the deafferented neostriatum by nigral transplants. Nature (Lond) 289: 497–499

    Google Scholar 

  • Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurobiology 80: 4546–4550

    Google Scholar 

  • Burns RS, LeWitt PA, Ebert MH, Pakkenberg H, Kopin IJ (1985) The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). New England J Med 312: 1418–1421

    Google Scholar 

  • Chiueh CC, Markey SP, Burns RS, Johannessen JN, Jacobowitz DM, Kopin IJ (1984) Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rat guinea pig and monkey. Psychopharmacol Bull 20: 548–553

    Google Scholar 

  • Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ (1985) III Primate model of Parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-1–4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Sci 36: 213–218

    Google Scholar 

  • Collier TJ, Redmond, DE Jr, Sladek CD, Gallagher MJ, Roth RH, Sladek JR Jr (1987a) Intracerebral grafting and culture of cryopreserved primate dopamine neurons. Brain Res 436: 363–366

    Google Scholar 

  • Collier TJ, Redmond, DE Jr, Roth RH, Sladek JR Jr (1987b) Neural cell replacement in a primate model of parkinsonism. Banbury report 27: Cold Spring Harbor Laboratory

  • Degryse A-D, Colpaert FC (1986) Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)]. Brain Res Bull 16: 561–571

    Google Scholar 

  • Diamond A (1989) Frontal lobe involvement in cognitive changes during the first year of life. In: Gibson K, Konner M, Petersen A (eds) Brain and behavioral development. Aldine Press, NY

    Google Scholar 

  • Di Paolo T, Bedard P, Daigle M, Boucher R (1986) Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys. Brain Res 379: 286–293

    Google Scholar 

  • Doudet D, Gross C, Lebrun-Grandie P, Bioulac B (1985) MPTP primate model of Parkinson's disease: a mechanographic and electromyographic study. Brain Res 335: 194–199

    Google Scholar 

  • Doudet D, Gross C, Lebrun-Grandie P, Bioulac B (1986) Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkeys: mechanographic and electromyographic data. Electromyogr Clin Neurophysiol 26: 11–727

    Google Scholar 

  • Eidelberg E, Brooks BA, Morgan WW, Walden JG, Kokemoor RH (1986) Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydroprydine model of parkinsonism in monkeys. Neuroscience 18: 817–822

    Google Scholar 

  • Elsworth JD, Deutch AY, Redmond DE Jr, Sladek JR Jr, Roth RH (1987a) Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridme (MPTP) on catecholamines and metabolites in primate brain and CSF. Brain Res 415: 293–299

    Google Scholar 

  • Elsworth JD, Deutch AY, Redmond DE Jr, Sladek JR Jr, Roth RH (1987b) Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum. Life Sci 40: 193–202

    Google Scholar 

  • Elsworth JD, Deutch AY, Redmond DE Jr, Taylor JR, Sladek JR Jr, Roth RH (1989) Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated primates: biochemical changes in striatal regions. Neuroscience 33: 323–331

    Google Scholar 

  • Elsworth JD, Redmond DE Jr, Sladek JR Jr, Deutch AY, Collier TJ, Roth RH (1990) Reversal of MPTP induced parkinsonism in primates by fetal dopamine cell transplants. In: AJ Franks, JW Ironside, RHS Mindham, RJ Smith, EGS Spokes, W Winlow (eds) Function and dysfunction of the basal ganglia. University Press, Manchester, pp 161–181

    Google Scholar 

  • Gash D, Sladek JR, Sladek CD, (1980) Functional development of grafted vasopression neurons. Science 201: 1367–1369

    Google Scholar 

  • Jenner P, Marsden CD (1986) The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. J Neural Transmiss Suppl XX: 11–39

    Google Scholar 

  • Kitt CA, Cork LC, Eidelberg F, Joh TH, Price DL (1986) Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in the monkey. Neuroscience 17: 1089–1103

    Google Scholar 

  • Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979–980

    Google Scholar 

  • Langston JW, Forno LS, Rebert CS, Irwin I (1984) Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 292: 390–394

    Google Scholar 

  • Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson's disease. Brain 106: 257–270

    Google Scholar 

  • Lockman JL (1984) The development of detour ability during infancy. Child Dev 55: 482–491

    Google Scholar 

  • Loranger AW, Goodell H, McDownell FH, Lee JE, Sweet RD (1972) Intellectual impairment in Parkinson's syndrome. Brain 95: 405–412

    Google Scholar 

  • Lund RA, Hauschka SD (1976) Transplanted neural tissue develops connections with host rat brain. Science 193: 582–584

    Google Scholar 

  • Mitchel IJ, Cross AJ, Sambrook MA, Crossman AR (1986) N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism. J Neural Transm Suppl XX: 41–46

    Google Scholar 

  • Nomoto M, Jenner P, Marsden CD (1986) Alterations in motor behavior produced by the isomers of 3-PPP in the MPTP-treated marmoset. Europ J Pharmacol 121: 123–128

    Google Scholar 

  • Perlow MJ, Freed WJ, Hoffer BJ, Seiger A, Olson L, Wyatt RJ (1979) Brain grafts reduce motor abnormalities produced by destruction of the nigrostriatal dopamine system. Science 204: 643–647

    Google Scholar 

  • Redmond DE Jr, Sladek JR Jr, Deutch AY, Haber SN (1986) Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet (8490) 1125–1127

  • Redmond DE Jr, Sladek JR Jr, Roth RH (1987) Transplanted cells: a future treatment for Parkinson's disease? Neuro Consult 4(2): 1–8

    Google Scholar 

  • Redmond, DE Jr, Sladek JR Jr, Roth RH, Collier TJ, Elsworth JD, Taylor, JR, Deutch AY, Haber SN (1988) Transplanted fetal dopamine neurons: a future treatment for Parkinson's disease? In: Sandler M, Dahlström A, Belmaker RH (eds) Progress in catecholamine research, Part B. Central aspects. Alan Liss Inc, NY, pp 117–123

    Google Scholar 

  • Reitan RM, Boll TJ (1971) Intellectual and cognitive functions in Parkinson's disease. J Consult Clin Psychol 37: 364–369

    Google Scholar 

  • Schneider JS, Yuwiler A, Markham CH (1987) Selective loss of subpopulations of ventral mesencephalic dopamine neurons in the monkey following exposure to MPTP. Brain Res 411: 144–150

    Google Scholar 

  • Schneider JS, Unguez, G, Yuwiler A, Berg SC, Markham CH (1988) Deficits in operant behaviour in monkeys treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Brain 111: 1265–1285

    Google Scholar 

  • Schultz W, Studer A, Jonsson G, Sundstrom E, Mefford I (1985) Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism. Neurosci Lett 59: 225–232

    Google Scholar 

  • Sladek JR Jr, Hoffman G (1983) Simultaneous analysis of monoaminergic and peptidergic neurons. In: Barker J, McKelvy J (eds) Current methods in cellular neurobiology. Wiley and Sons, NY, pp 203–217

    Google Scholar 

  • Sladek JR Jr, Collier TJ, Haber SN, Roth RH, Redmond DE Jr (1986) Survival and growth for fetal catecholamine neurons transplanted into primate brain. Brain Res Bull 17: 809–818

    Google Scholar 

  • Sladek JR Jr, Redmond DE Jr, Collier TJ, Haber SN, Elsworth JD, Deutch AY, Roth RH (1987a) Transplantation of fetal dopamine neurons in primate brain reverses MPTP induced parkinsonism. Progr Brain Res 71: 309–322

    Google Scholar 

  • Sladek JR Jr, Collier TJ, Haber SN, Deutch AY, Elsworth JD, Roth RH, Redmond DE Jr (1987b) Reversal of parkinsonism by fetal nerve cell transplants in primate brain. Ann NY Acad Sci 495: 641–657

    Google Scholar 

  • Sladek JR Jr, Redmond DE Jr, Collier TJ, Blount JP, Elsworth JD, Taylor JR, Roth RH (1988a) Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydrapyridine-induced parkinsonism in monkeys. Progr Brain Res 78: 497–506

    Google Scholar 

  • Sladek JR Jr, Redmond DE Jr, Roth RH (1988b) Transplantation of fetal neurons in primates. Clin Res 36: 200–204

    Google Scholar 

  • Stern Y, Langston W (1985) Intellectual changes in patients with MPTP-induced parkinsonism. Neurology 35: 1506–1509

    Google Scholar 

  • Stern Y, Mayeux R, Rosen J, Ilson J (1983) Perceptual motor dysfunction in parkinson's disease: a deficit in sequential and predictive voluntary movement. J Neurol Neurosurg Psychiatr 46: 145–151

    Google Scholar 

  • Taylor JR, Elsworth JD, Roth RH, Sladek JR Jr, Redmond DE Jr (1990a) Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain 113: 617–637

    Google Scholar 

  • Taylor JR, Roth RH, Sladek JR Jr, Redmond DE Jr (1990b) Cognitive and motor deficits in the performance of an object retrieval task with barrier/detour in monkeys treated with MPTP: long-term performance and effect of transparency of the barrier. Behav Neurosci 104: 564–576

    Google Scholar 

  • Taylor JR, Elsworth JD, Roth RH, Collier TJ, Sladek JR Jr, Redmond DE Jr (1990c) Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeys. Progr Brain Res 82 (in press)

  • US Public Health Service (1985) Guide for the care and use of animals US Government Printing Office, Washington DC

    Google Scholar 

  • Weingartner H, Burns S, Diebel R, LeWitt PA (1984) Cognitive impairments in Parkinson's disease: distinguishing between effort-demanding and automatic cognitive processes. Psychiat Res 11: 223–235

    Google Scholar 

  • Winer BJ (1974) Statistical principles in experimental design, 2nd edn. McGraw Hill, New York

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurobehavior Laboratory and Department of Psychiatry and Pharmacology, Yale University School of Medicine, 333 Cedar Street, 06510, New Haven, CT, USA

    J. R. Taylor, J. D. Elsworth, R. H. Roth & D. E. Redmond Jr.

  2. Department of Neurobiology and Anatomy, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, 14642, Rochester, NY, USA

    J. R. Sladek Jr. & T. J. Collier

Authors
  1. J. R. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. D. Elsworth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. H. Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. R. Sladek Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. J. Collier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. E. Redmond Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, J.R., Elsworth, J.D., Roth, R.H. et al. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls. Exp Brain Res 85, 335–348 (1991). https://doi.org/10.1007/BF00229411

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00229411

Key words

Search

Navigation